Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Current Opinion in Investigational Drugs (London, England : 2000)
|
June 3, 2008
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors
Scott N Pinchot, Susan C Pitt, Rebecca S Sippel, et al.
The Oncologist
|
July 26, 2012
Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a prospective cohort study
Scott N Pinchot, Linda Youngwirth, Victoria Rajamanickam, et al.
The Journal of Surgical Research
|
September 22, 2009
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype
Jui-yu Chen, Mackenzie R Cook, Scott N Pinchot, et al.
Annals of Surgical Oncology
|
September 4, 2012
Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors
Narek Shaverdian, Scott N Pinchot, Barbara Zarebczan, et al.
Molecular Cancer Therapeutics
|
January 28, 2010
Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth
Mackenzie R Cook, Scott N Pinchot, Renata Jaskula-Sztul, et al.
Cancer
|
March 23, 2011
Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method
Scott N Pinchot, Renata Jaskula-Sztul, Li Ning, et al.
American Journal of Surgery
|
February 28, 2009
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway
Scott N Pinchot, Joel T Adler, Yinggang Luo, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 11, 2014
What is the effect of stoma construction on surgical site infection after colorectal surgery?
Rocco Ricciardi, Patricia L Roberts, Jason F Hall, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Current Opinion in Investigational Drugs (London, England : 2000)
|
June 3, 2008
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors
Scott N Pinchot, Susan C Pitt, Rebecca S Sippel, et al.
The Oncologist
|
July 26, 2012
Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a prospective cohort study
Scott N Pinchot, Linda Youngwirth, Victoria Rajamanickam, et al.
The Journal of Surgical Research
|
September 22, 2009
MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype
Jui-yu Chen, Mackenzie R Cook, Scott N Pinchot, et al.
Annals of Surgical Oncology
|
September 4, 2012
Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors
Narek Shaverdian, Scott N Pinchot, Barbara Zarebczan, et al.
Molecular Cancer Therapeutics
|
January 28, 2010
Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth
Mackenzie R Cook, Scott N Pinchot, Renata Jaskula-Sztul, et al.
Cancer
|
March 23, 2011
Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method
Scott N Pinchot, Renata Jaskula-Sztul, Li Ning, et al.
American Journal of Surgery
|
February 28, 2009
Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway
Scott N Pinchot, Joel T Adler, Yinggang Luo, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
January 11, 2014
What is the effect of stoma construction on surgical site infection after colorectal surgery?
Rocco Ricciardi, Patricia L Roberts, Jason F Hall, et al.
Page
of 2